Novartis India Limited has dispatched physical letters containing the weblink for its 78th Annual General Meeting (AGM) and the Annual Report for FY26 to shareholders who have not registered their email addresses. The Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, sent these communications on September 3, 2026.

This physical dispatch complements the electronic distribution completed earlier on September 2, 2026, ensuring all shareholders receive the necessary documentation in compliance with SEBI Listing Regulations.

Dispatch Details

The physical letters were dispatched to members who had not registered their email addresses with the company, any Depository, or the RTA as of the cut-off date of August 25, 2026. The company received confirmation of this dispatch from the RTA on September 4, 2026.

The communication includes the direct weblink to the Annual Report for FY26, available at: https://nilpharma.co.in/pdfs/investors/agm/Novartis%20Annual%20Report_2026.pdf .

AGM Schedule and Voting

The 78th AGM is scheduled for Thursday, September 24, 2026, at 11:00 am. The meeting will be conducted via Video Conferencing or Other Audio-Visual Means.

Remote e-voting will commence on Monday, September 21, 2026, at 9:00 am and conclude on Wednesday, September 23, 2026, at 5:00 pm. Shareholders holding shares as on the cut-off date of Thursday, September 17, 2026, are eligible to vote.

Members attending the AGM who did not cast their votes remotely may vote electronically during the meeting. This process adheres to Section 108 of the Companies Act, 2013, and Regulation 44 of the SEBI Listing Regulations.

Regulatory Compliance and KYC Updates

The intimation regarding the completion of the electronic dispatch was published in Financial Express (English – All editions) and Navshakti (Marathi – Mumbai). The physical dispatch notification was filed with BSE Limited on September 9, 2026.

The letter also serves as a reminder for shareholders holding physical securities to update their KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 7, 2024. Shareholders are requested to dematerialise physical securities and update PAN, address, mobile number, bank account details, specimen signature, and nomination choices.

Payments for folios without updated KYC details will only be made electronically with effect from April 1, 2024. Shareholders can access the required forms and circulars at https://web.in.mpms.mufg.com/KYC-downloads.html .

Novartis India Limited will hold its analyst and institutional investor meeting on Thursday, September 10, 2026. The company updated the schedule from the previously announced September 11 date, maintaining the 4:00 pm start time.

Meeting Details

The event is scheduled for 4:00 pm and will be held in Mumbai. It operates as a general group meeting available through both virtual and physical modes. The company noted that the schedule may change due to exigencies on the part of investors, analysts, or the company.

Participation and Disclosure

Participants interested in attending are requested to confirm their presence by writing to investor.relations@nilpharma.co.in . The company emphasized that discussions will refer only to publicly available information. No unpublished price-sensitive information will be shared during the session.

The presentation for the meeting will be made available before the event on the BSE Limited website and the company’s official website at https://nilpharma.co.in/ . The intimation was issued pursuant to Regulation 30 read with Schedule III Part A Para A sub-para 15 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Chandni Maru, Company Secretary and Compliance Officer, signed the disclosure.